THOUSAND OAKS, Calif., Dec. 1 -- Amgen
(Nasdaq: AMGN), the world´s largest biotechnology company, today announced
that it would provide financial guidance for 2004 on a conference call with
the investment community on Monday, December 15, 2003, at 2:00 p.m. PST.
Participating in the call from Amgen will be Kevin Sharer, Chairman, Chief
Executive Officer, and President, and other members of Amgen´s senior
Live audio of the conference call will be simultaneously broadcast over
the Internet and will be available to members of the news media, investors and
the general public. The conference call is expected to last approximately
This event can be accessed by going to Amgen´s website, www.amgen.com ,
and clicking on Investors, then on Amgen Events. The event will be archived
and available for replay for 72 hours after the event.
Amgen is a global biotechnology company that discovers, develops,
manufactures and markets important human therapeutics based on advances in
cellular and molecular biology.
CONTACT: Amgen, Thousand Oaks
Sabrina Johnson, (805) 447-4587 (media)
Cary Rosansky, (805) 447-1060 (investors)
EDITOR´S NOTE: An electronic version of this news release may be accessed
via our Web site at www.amgen.com . Journalists and media representatives may
sign up to receive all news releases electronically at time of announcement by
filling out a short form in the Media section of the Web site.